comparemela.com

Latest Breaking News On - Strategic commercialization organization - Page 1 : comparemela.com

Nextremity Solutions Inc Announces Completion of Acquisition by Medartis and Announces New US Leadership

Nextremity Solutions, Inc Announces 510(k) Clearance of the StealthFix™ Intraosseous Fixation System

Warsaw, Indiana (PRWEB) April 21, 2022 Nextremity Solutions, Inc., a Strategic Commercialization Organization (SCO) with a focus on the extremity

Privately Held Nextremity Solutions, Inc to be Acquired by Medartis to Expand Its Lower and Upper Extremities Business in the US

Nextremity Solutions Announces Upcoming Commercial Launch of LapiPrep®, a New Lapidus Correction and Preparation System

Nextremity Solutions, Inc Announces Commercialization of Intraosseous Fixation Platform for Use in Extremities

Nextremity Solutions, Inc. Announces Commercialization of Intraosseous Fixation Platform for Use in Extremities Share Article I look forward to bringing this treatment option to my patients. WARSAW, Ind. (PRWEB) March 11, 2021 Nextremity Solutions, Inc., a Strategic Commercialization Organization (SCO) with a focus on the extremity musculoskeletal space, located in “The Orthopedic Capital of the World,” Warsaw, Ind., announced that it will begin commercialization efforts of its StealthFix™ intraosseous fixation platform; a novel fixation platform for use in both upper and lower extremities. StealthFix is an intraosseous small bone fixation system for the treatment of arthrodesis, osteotomies and bone fractures. Devices that are currently used in the treatment of these indications are bone plates, staples and screws. The majority of these treatment options are placed on bone. The prominence of these device

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.